N-Nitroso Compounds

381 Pages·1981·5.426 MB·English

by  Richard A. Scanlan and Steven R. Tannenbaum (Eds.)

1
0
0
w
4.f
7
1
1-0 N-Nitroso Compounds
8
9
1
k-
b
1/
2
0
1
0.
1
oi:
d
1 |
8
9
1
9,
er
b
m
e
c
e
D
e:
at
D
n
o
ati
c
bli
u
P
1
0
0
w
4.f
7
1
0
1-
8
9
1
k-
b
1/
2
0
1
0.
1
oi:
d
1 |
8
9
1
9,
er
b
m
e
c
e
D
e:
at
D
n
o
ati
c
bli
u
P
N-Nitroso Compounds

Richard A. Scanlan, EDITOR
Oregon State University
Steven R. Tannenbaum, EDITOR
1 Massachusetts Institute of Technology
0
0
w
4.f
7
1
0
1-
8
9
1
bk- Based on a symposium
1/
2
0
1
0. cosponsored by the Divisions of
1
oi:
d
1 | Agricultural and Food Chemistry
8
9
1
9,
er and Pesticide Chemistry
b
m
e
c
e at the 181st Meeting of the
D
e:
at
D
n American Chemical Society,
o
ati
c
bli Atlanta, Georgia,
u
P

March 31-April 1, 1981.

ACS SYMPOSIUM SERIES 174
AMERICAN CHEMICAL SOCIETY
WASHINGTON, D. C. 1981
1
0
0
w Library of Congress CIP Data
74.f N-nitroso compounds.
1
0
1- (ACS symposium series, ISSN 0097-6156; 174)
98 "Based on a symposium cosponsored by the Divi­
k-1 sions of Agricultural and Food Chemistry and Pesti­
b cide Chemistry at the 181st meeting of the American
21/ Chemical Society, Atlanta, Georgia, March 31-April
10 1, 1981."
0.
1 Includes bibliographies and index.
oi: 1. Nitroso-compounds—Congresses. 2. Nitroso-
81 | d aNmitrinoseos—-coCmopnogurnesdsse—s. M3e.t abCoalricsmino—geCnos—ngrCeossnegsr.e sses. 4.
19 I. Scanlan, Richard Α., 1937- . II. Tannenbaum,
9, Steven R., 1937- . III. American Chemical Society.
er Division of Agricultural and Food Chemistry. IV.
b American Chemical Society. Division of Pesticide
m
e Chemistry. V. Series.
c
e
D RC268.7.N58N18 616.99'4071 81-19047
e: ISBN 0-8412-0667-8 AACR2
Dat ACSMC8 174 1-400 1981
n
o
ati
c Copyright © 1981
bli
Pu American Chemical Society

All Rights Reserved. The appearance of the code at the bottom of the first page of each
article in this volume indicates the copyright owners consent that reprographic copies of
the article may be made for personal or internal use or for the personal or internal use of
specific clients. This consent is given on the condition, however, that the copier pay the
stated per copy fee through the Copyright Clearance Center, Inc. for copying beyond that
permitted by Sections 107 or 108 of the U.S. Copyright Law. This consent does not extend
to copying of transmission by any means—graphic or electronic—for any other purpose,
such as for general distribution, for advertising or promotional purposes, for creating new
collective work, for resale, or for information storage and retrieval systems.
The citation of trade names and/or names of manufacturers in this publication is not to be
construed as an endorsement or as approval by ACS of the commercial products or services
referenced herein; nor should the mere reference herein to any drawing, specification,
chemical process, or other data be regarded as a license or as a conveyance of any right or
permission, to the holder, reader, or any other person or corporation, to manufacture, repro­
duce, use, or sell any patented invention or copyrighted work that may in any way be
related thereto.
PRINTED IN THE UNITED STATES OF AMERICA
ACS Symposium Series
M. Joan Comstock, Series Editor
1
0
0
w
4.f
7
1
0
1- Advisory Board
8
9
1
k-
b David L. Allara James P. Lodge
1/
2
0
1
0. Kenneth B. Bischoff Marvin Margoshes
1
oi:
1 | d Donald D. Dollberg Leon Petrakis
8
9
9, 1 Robert E. Feeney Theodore Provder
er
b
m Jack Halpern F. Sherwood Rowland
e
c
e
D
e: Brian M. Harney Dennis Schuetzle
at
D
on W. Jeffrey Howe Davis L. Temple, Jr.
ati
c
bli James D. Idol, Jr. Gunter Zweig
u
P
01 FOREWORD
0
w
4.f
7
01 The ACS SYMPOSIUM SERIES was founded in 1974 to provide
1-
8 a medium for publishing symposia quickly in book form. The
9
1
k- format of the Series parallels that of the continuing ADVANCES
b
1/ IN CHEMISTRY SERIES except that in order to save time the
2
0
1 papers are not typeset but are reproduced as they are sub
0.
oi: 1 mitted by the authors in camera-ready form. Papers are re
d viewed under the supervision of the Editors with the assistance
81 | of the Series Advisory Board and are selected to maintain the
9
9, 1 integrity of the symposia; however, verbatim reproductions of
er previously published papers are not accepted. Both reviews
b
m and reports of research are acceptable since symposia may
e
c
De embrace both types of presentation.
e:
at
D
n
o
ati
c
bli
u
P
PREFACE
It is approximately twenty-five years since John Barnes and Peter Magee
discovered that dimethylnitrosamine was a carcinogen for the rat. Since
that time N-nitroso compounds have come to be among the most impor
tant experimental mutagens and carcinogens for laboratory investigation.
Equally, if not more importantly, they have come to be viewed as one of
1
00 the most important classes of environmental carcinogens, and the potential
pr
4. for endogenous formation from ubiquitous precursors has been recognized.
7
01 Their presence and the presence of their precursors in foods, water, air, and
1-
8 industrial and agricultural products has led to frantic calls for legislative
9
1
k- and regulatory action, and a never-ending search for more sensitive and
b
1/ specific methods of analysis.
2
0
1 The symposium upon which this volume is based was organized at a
0.
oi: 1 turning point in nitrosamine research. Almost all types of commercial
d products have been tested for volatile nitrosamines, and there have been
81 | a number of outstanding accomplishments of combined university-gov
9
9, 1 ernment-private industry actions to lower or eliminate volatile nitrosa
er mines in those products found to be contaminated. However, there is still
b
m a major gap of knowledge with regard to compounds that are not amenable
e
c
De to analysis by gas chromatography, and this is clearly a frontier of current
e: research. There are also many important questions regarding chemistry,
at
n D mechanism of action, and relation to human disease whose answers lie in
o
ati the future of research in this field.
c
bli It is the purpose of this volume to summarize the current state of
u
P knowledge of nitrosamine research with a chemical orientation, and to

help lead the way into the future.
RICHARD A. SCANLAN
Oregon State University
Corvallis, OR 97331
STEVEN R. TANNENBAUM
Massachusetts Institute of Technology
Cambridge, MA 02139
July 31, 1981
ix
1
Activation of Nitrosamines to Biological
Alkylating Agents
C. J. MICHEJDA, M. B. KROEGER-KOEPKE, S. R. KOEPKE,
and D. H. SIEH
Chemical Carcinogenesis Program, Frederick Cancer Research Center,
Frederick, MD 21701
1
0
0
h
4.c N-Nitrosamines require metabolic activation to
17 generate the reactive species which result in tumor
0
1- induction. The most commonly accepted hypothesis
8
9 for this activation is the α-hydroxylation hypothe­
1
k- sis. Nitrosamines which have hydrogens on the alpha
b
1/ carbons are hydroxylated in that position by a
2
0 mixed function oxygenase. The resultant α-hydroxy-
1
0. alkyl nitrosamine breaks down to an alkyldiazon-
1
oi: ium ion and the corresponding carbonyl compound.
1 | d The diazonium ion alkylates a variety of nucleophiles
8 and releases molecular nitrogen. The determination
9
9, 1 of the amount of molecular nitrogen provides a
er measure of the extent of α-hydroxylation. This con­
mb cept was applied to the in vitro metabolism of
ce doubly [15N]-labeled dimethylnitrosamine (DMN) and
e
D N-nitrosomethylaniline (NMA) by uninduced rat liver
ate: S-9 (the postmitochondrial fraction). The amount
D of total metabolism was determined by the measurement
n
o of nitrosamine loss. It was found that measurement
cati of formaldehyde formation gave an artificially low
ubli value of nitrosamine metabolism. The in vitro re­
P
sults indicated that about 34% of the DMN metabolism
proceeded by a α-hydroxylation, while only 19% of the
theoretical nitrogen was released by NMA. A similar
experiment in vivo, using [15N]-labeled DMN showed
that about 66% of the metabolism proceeded by α-
hydroxylation.
Alternative pathways of activation of nitros­
amines, including β-hydroxylation followed by sul­
fate conjugation and the formation of alkoxydiazen-
ium ions are discussed. The formation of alkyldiazo-
nium ions from trialkyltriazenes is presented to show
that the formation of the putative ultimate carcino­
gens from nitrosamines can be studied in a system not
requiring metabolic activation.
0097-6156/81/0174-0003$05.00/0
© 1981 American Chemical Society
4 JV-NITROSO COMPOUNDS
In 1956 Magee and Barnes (1) reported that dimethylnitros-
amine (DMN) was a potent carcinogen in rats* This discovery
initiated a mighty outburst of research activity. There are
now thousands of papers dealing with the chemistry, metabolism,
mutagenicity, teratogenicity, and carcinogenicity of nitros­
amines and other N-nitroso compounds. There are several rea­
sons for this continuing interest. Practically all nitros­
amines are carcinogenic, making them the largest single chemi­
cal group which has that property. In fact, non-carcinogens
among them may provide important clues to what makes nitros­
amines carcinogenic. Nitrosamines are remarkably site speci­
fic; essentially all the organs are effected by one or another
nitrosamine (JJ). This makes nitrosamines excellent tools for
1 the study of mechanisms of chemical carcinogenesis. Perhaps
0
0 most importantly, nitrosamines can be and are formed in the
h
4.c human environment. The reason for this is that the two precur­
17 sors to nitrosamines, nitrite and amines, are ubiquitous com­
0
1- ponents of the environmental mix. Moreover, nitrosamines can
8
9 be formed in the stomach by ingesting the precursor amines and
1
k- nitrite. Several chapters in this volume concern themselves
b
1/ with environmental and dietary aspects of nitrosamines.
2
0
0.1 The first ten years of nitrosamine research, particularly
doi: 1 wrietvhi ewr esbpy ecMta gteoe caarndc inBoagrenneess i(s^,3 )w.e reS isnucmem atrhiazte dt iimne ana n ademniorrambolue s
1 | amount of work has been carried out on those substances. Some
8
9 of this work up to 1974 was reviewed by Magee, Montesano and
1
9, Preussmann (j4). Recently, Lai and Arcos (5) provided a useful
er synopsis of contemporary work on the bioactivation of some
b
m selected dialkylnitrosamines.
e
c
e Nitrosamines, in common with many other organic carcino­
D
e: gens, have to be metabolized before their carcinogenic potential
Dat can be expressed. Thus, Magee (£) in 1956 showed that dimethyl-
n nitrosamine (DMN) was cleared rapidly from the bodies of rats,
o
ati mice, and rabbits, with very little being excreted in the urine
c
bli or the feces. Dutton and Heath (J) reported that [^CJ-DMN
Pu was metabolized in rats and mice, with a major portion of l^C

appearing in expired carbon dioxide, with the rest of the radio­
activity being evenly distributed in the tissues. Only about
7% of the radioactivity was found in the urine. These workers
also postulated that the metabolism proceeded by a demethylation
reaction and concluded that the lesions produced by DMN were
the result of the interaction of metabolites of DMN with cellu­
lar components, rather than with the intact DMN. Since the
liver was the principal target of DMN, Magee and Vandekar (J£)
used liver slices and subcellular fractions to study the in
vitro metabolism of DMN. They found that the metabolizing activ­
ity was localized in the microsomes and in the cytosol and that
it required molecular oxygen and the presence of NADPH. The
formation of formaldehyde from DMN was demonstrated by Brouwers
and Emmelot (Jj)). The principal enzyme system responsible for
1. MICHEJDA ET AL. Biological Alkylating Agents 5
DMN oxidative demethylation has been shown to be a liver mi­
crosome cytochrome P-450 monooxygenase (10)» Lotlikar et
al» (11) found that a reconstituted enzyme system, consisting
of cytochrome P-450, NADPH-cytοchrome P-450 reductase and
phosphatidyl choline was effective in catalyzing the demethy­
lation of DMN. The most commonly accepted mechanism for the
oxidative demethylation of DMN and, by extension, of other
dialkylnitrosamines is shown in Scheme 1.
Scheme 1
0
2
R - Ν - CHo-R1 ». R - Ν - CH - Rf
2
01 NI O NeAnDzPyHme NI O I
0
h
c
74. t R»'(CH O
1
0 R - Ν = Ν - OH ^ RNH-NO
81- A
9
k-1 -OH
1/b cellular
2
0 RN+ * R - Nu + N
0.1 2 nucleophiles 2
1
oi:
d The α-Hydroxylation Hypothesis
1 |
8
19 The above scheme satisfies much of the metabolic data;
ber 9, hploewteev.e r,T hsoem eev iodfe nicte i sf sopre ctuhlea tfiovrem,a tainond iotf itsh cee rαt-ahiyndlyr oxiynlcaotme­d
m
e intermediate is circumstantial. The acetate ester of a-
c
De hydroxylated dimethylnitrosamine has been prepared (12.13)
e: and has been found to be a potent, directly acting carcinogen
at
D (14). Other esters of a variety of α-hydroxylated nitros­
on amines have also been prepared (15). While it has been
cati shown that DMN acetate is hydrolyzed to hydroxymethylmethyl-
bli nitrosamine by an esterase enzyme, it has been pointed out
u
P that these derivatives of the ot-hydroxylated nitrosamines
also dissociate to N-nitrosoimmonium ions (ϋ, 16).
Wiessler (15) suggested that the nitrosoimmonium ion
could act as the electrophile which alkylates cellular nucleo­
philes.
OAc" π
HC CH0Ac HC. CH [ Nu;^Nu-CH3 + Ν
3 V / 2 3 ; 2
I
ι N-0
NO N=0